- Current Federal Budget Template & Non-Federal Budget Template
- NDAA (National Defense Authorization Act) Section 889 Compliance (effective July 2020)
- Resumption of In-Person Healthcare Services
- Test Page – Reporting
- Site Map
- Wiki
- Project Lifecycle
- Find Funding
- Prepare a Proposal
- Proposal Review and Submission
- Award Review and Acceptance
- Award Setup
- Manage an Award
- Conducting Research
- Close Out an Award
- Bring to Market
- Publication
- Industry Collaboration
- Licensing
- Start a Company
- Learning Paths & Programs
- Pitching to Find a CEO
- Catalyst Program
- Grant Writing: The Commercialization Plan
- Guide Program
- Invasion of the Equity Investors Program
- Mentor Program
- OTD Analyst Program
- Pitch Workshop
- Pitching for SRAs
- Pitching to Licensees
- Products Designed for Adoption
- Regulatory Obligations for a New Medical Product
- Reimbursement Analysis and Strategy Guidance
- Spark Program
- Tutoring Program: Materials and Hardware
- Tools & Resources
- Contact Technology Development
- Bring to Market FAQs
- Newsletter Sign-up
- Contact OTD
- Innovator of the Year
- Technologies Available for License
- Promote Your Work
- Compliance
- Federal Requirements
- Research and Development National Security Policy Guidance
- Federal Screening
- Animal Care & Use
- Announcements
- Animal Operations (AOps) System
- BU Statement on Animal Research
- Obtaining and Transporting Animals
- Housing Animals
- Working with Animals
- Additives to the Drinking Water for Rats and Mice
- Anesthesia and Analgesia
- Breeding
- Conditional Use of Expired Medical Materials (IACUC)
- Environmental Enrichment
- Euthanasia
- Fertilized and Embryonated Chicken Eggs
- Food Regulation and Restriction in Rodents
- Personal Protective Equipment (PPE)
- Phenotype
- Procedures
- Adjuvants
- Administration Of Drugs and Experimental Compounds in Mice and Rats
- Ascites
- Blood Collection Guidelines
- Biological Materials in Rodents
- Body Condition Scoring for Mice
- Collection of tissues for genotyping
- Irradiation of Rodents
- Osmotic Pumps in Mice and Rats
- Search for Alternatives (IACUC)
- Surgery: Aseptic
- Surgery: Rodent
- Thioglycollate
- Tumor Policy for mice and rats
- Use of Pharmaceutical-grade chemicals and other substances (IACUC)
- Recognizing Pain and Distress in Animals
- Research with Animals
- Rodent Fluid Regulation
- Special Care Request
- Zoonoses
- Mouse Assisted Reproductive Technology (MART) Core
- Standard Operating Procedures
- Institutional Animal Care & Use (IACUC)
- Animal Care Training
- Reporting: Violation and Complaint Resolution (IACUC)
- Federal Regulations, Laws, and Guidelines
- Scientific Diving and Small Boat Safety
- Export Control
- Financial Conflicts of Interest
- Human Subjects
- Amendments & Modifications
- Annual Review
- Determining if IRB Approval is Needed
- Email Sign-up
- Guidance for Adding External Investigators
- Guidance on Data Security
- Human Subjects Training
- HIPAA
- Initial Submissions
- Responding to the IRB
- Submission Timelines
- Office Hours & Services
- Quality Improvement and Post Approval Resources
- Research Participation
- Responsibilities, Ethics, and Regulations
- Tips for Creating a Consent Document
- IRB Members
- Institutional Biosafety Committee
- About the IBC
- Applications
- Dual Use Research of Concern
- IBC Policies
- Guidelines for the Use of Human Embryonic Stem Cells
- Inactivated Biological Sample Use
- Incident Reporting Requirements for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
- Inoculation of Viral Vectors in Laboratory Rodents
- Obtaining USDA and CDC Permits for Importing and Transferring Animal Pathogens and Related Biological Materials
- Responsibility of the Principal Investigator
- Transgenic Rodent Guidelines
- Verification of Attenuated Biosafety Level 3 (BSL-3) Pathogens Policy
- Training and Health Clearance Requirements
- Resources
- Biosafety Manual
- Chapter 1: Biological Safety Program: Purpose, Scope, and Responsibilities
- Chapter 2: Approval of Research Projects
- Chapter 3: List of Regulations and Guidelines
- Chapter 4: Biosafety Principles
- Chapter 5: Laboratory Biosafety Practices
- Chapter 6: Laboratory Training
- Chapter 7: Decontamination and Sterilization
- Chapter 8: Biohazardous Spill Response
- Chapter 9: Biohazardous and Medical Waste Disposal
- Chapter 10: Federal Select Agent Program
- Chapter 11: Transportation of Biological Materials
- Appendix A: Importation and Exportation of Infectious Biological Agents
- Appendix B: Laboratory Ventilation and Containment for Biosafety
- Appendix C: Autoclave Quality Assurance Program
- Appendix D: Biosafety Level 2 (BSL2) Requirements
- Appendix E: Biosafety Level 3 (BSL3) and Biosafety Level 4 (BSL4) Requirements and Practices
- Appendix F: Guidelines for Work with T
- Appendix G: List of Biological Agents with the Potential to Cause Laboratory Acquired Infection (LAI) in Use at Boston University
- Appendix H: Prion Research/Creutzfeldt-Jacob Disease (CJD) Guidelines
- Appendix I: Summary of Requirements for Biosafety Levels
- Appendix J: Summary of Requirements for Animal Biosafety Levels
- Appendix K: Bloodborne Pathogen Standard
- Appendix L: Working Safely with Animals
- Appendix M: Procedures for Working in an Animal Biosafety Level 2 (ABSL2) Facility at BU
- Appendix N: Verification of Attenuated Biosafety Level 3 (BSL-3) Pathogens Policy
- Appendix O: Boston Public Health Commission Requirements
- Appendix P: ROHP Medical Surveillance Program
- Appendix Q: Laboratory and Equipment Decontamination Procedures
- Appendix R: Laboratory Decommissioning and Relocation Procedures
- Appendix S: Laboratory Door Signage
- Appendix T: Boston University Research Compliance Policy on Disease Surveillance and Reporting for High-Risk Agents
- Appendix U: Criteria for Development of Standard Operating Procedures (SOP)
- Appendix V: Boston University Institutional Biosafety Committee Noncompliance Policy
- Appendix W: BSL-3 and BSL-4 Biosafety Plan
- Biosafety Bulletin Vol 2 Issue 1 – April 2015
- Biosafety Bulletin Vol 2 Issue 2 – October 2015
- Biosafety Bulletin Vol 2 Issue 3 – December 2015
- Biosafety Bulletin Vol 3 Issue 1 – April 2016
- Biosafety Bulletin Vol 3 Issue 2 – June 2016
- Biosafety Bulletin Vol 3 Issue 3 – October 2016
- Biosafety Bulletin Vol 4 Issue 1 – April 2017
- Biosafety Manual
- Training
- Laboratory Safety Resources
- Chemical Hygiene Plan
- Changes to OSHA Hazard Communication Standard
- Chemical Labeling
- Chemical Segregation and Storage Chart
- Field Research Resources
- Highly Hazardous Chemicals Program
- High Hazard Chemical List
- Highly Hazardous Chemicals Program Policy
- Highly Hazardous Chemicals Program Guidance Document
- Cyanides SOP Template
- Hydrofluoric Acid SOP Template
- Osmium Tetroxide SOP Template
- Perchloric Acid and Perchlorate Salts SOP Template
- Picric Acid SOP Template
- Pyrophoric SOP Template
- Pyrophoric SOP Teaching Lab Template
- PyroTox Gases SOP Template
- Laboratory Safety Committee Charter
- Personal Protection Equipment (PPE) in Laboratories Policy
- Annual Report LSC AY 2015
- Annual Report LSC AY 2014
- Annual Report LSC AY 2013
- Annual Report AY 2012 LSC BUMC
- Annual Report AY 2012 CRC LSC
- Annual Report AY 2011 BUMC LSC
- Annual Report AY 2011 CRC LSC
- Annual Report AY 2010 LSC BUMC
- Radiation Safety Committee
- Radiation Safety Committee Charter
- Radioisotope Use Manual
- Section 1: Introduction
- Section 2: ALARA Policy
- Section 3: Organization, Authority and Responsibility
- Section 4: Permitting for Radioactive Material Use
- Section 5: Radioisotope Safety Regulations and Policies
- Section 6: Purchase of Radioactive Materials and Devices
- Section 7: Working with Radioactive Materials and Devices
- Section 8: Radioactive Waste Management and Disposition of Radioactive Materials and Devices
- Appendix I: Radioisotope Laboratory Rules
- Appendix II: Permit Holder Responsibilities
- Appendix III: Research Radioisotope User Responsibilities
- Appendix IV: Boston University / Boston Medical Center Contamination Action Limits for Release
- Appendix V: DPH Notice to Employees
- Responsible Conduct of Research
- Forms & Policies
- Training & How To
- Best Practices for Grant Management
- Documentation Management
- Carryover and No Cost Extension Guidance
- Coffee with Colleagues Series
- Communications and Media Training
- Conflict of Interest Training
- Create a Digital Signature
- Environmental Health and Safety Training
- Grant Management Training Courses
- IACUC Training
- International Collaboration in Research & Scholarship
- PAFO Onboarding Pack for Department Administrators
- Responsible Conduct of Research Training
- RIMS Training
- Pre-Award Onboarding Pack
- Safety
- Culture of Safety & Responsibility
- Emergency Information & Contacts
- Research Occupational Health Program (ROHP)
- Requirements for Medical Clearance
- Agent Information Sheets
- Acanthamoeba castellanii
- Ascaris suum
- Brazilian Vaccinia virus
- Bunyavirues (Crimean Congo Hemorrhagic Fever Virus (CCHFV))
- Burkholderia cepacia
- Cache Valley virus (CVV)
- Chikungunya virus
- Chlamydia trachomatis
- Clostridium difficile
- Coronaviruses
- Cowpox brighton virus
- Coxsackie B Virus
- Dengue virus
- Ebola virus
- Enterohemorrhagic or Shiga-toxin E. coli
- Enteroviruses EV-D68, EV-D70, and EV-A71
- Filoviruses – Ebola and Marburg Viruses
- Francisella tularensis
- Haemophilus influenzae
- Heartland virus (HRTV)
- Herpes B Virus Non-human primates
- Human Immunodeficiency virus (HIV)
- Lymphocytic Choriomeningitis Virus (LCMV)
- Influenza
- Japanese Encephalitis virus
- KPC Klebsiella
- La Crosse encephalitis virus (LACV, LAC)
- Marburg virus
- Mayaro virus (MAYV)
- Measles
- MRSA
- Mumps
- Mycobacterium bovis/BCG
- Mycobacterium Tuberculosis
- Neisseria Gonorrhea
- Neisseria meningitidis
- Newcastle Disease virus
- New World Arenaviruses (Junin, Machupo, Guanarito, and Sabia viruses)
- Old World Arenaviruses (Lassa and Lujo viruses)
- Orthobunyaviruses
- Orthopoxviruses
- Paramyxoviruses (Hendra and Nipah Virus)
- Plasmodium spp.
- Polio
- Rabies virus
- Salmonella enterica species (S typhimurium and S. enteriditis serotypes)
- Sindbis virus (SINV)
- Snowshoe Hare Virus
- Streptococcus pyogenes
- Usutu virus (USUV)
- Vancomycin-resistant Enterococcus (VRE)
- Vibrio cholera pacini O1 biovar eltor str. N16961
- West Nile virus
- Yellow Fever Virus
- Yersinia enterocolitica
- Yersinia pestis
- Zika
- Assess and Avoid Risk
- Privacy Policy
- Quarterly Incident Reports
- Tuberculosis Screening
- CDC Vaccine Information Statements
- Reporting
- Tools & Services
- Core Facilities
- Biomedical Optics Laboratory
- Center for Molecular Discovery
- Center for Computational Science
- Chemical Instrumentation Center
- DAMP Lab
- Electronics Design Facility
- Fraunhofer Center for Manufacturing Innovation
- Geddes Language Center
- Micro-CT and X-ray Microscopy Imaging Facility
- Photonics Center Shared Facilities
- Proteomics and Imaging Core Facility
- Scientific Instrument Facility
- Pivot Database
- Dimensions Database
- Faculty Departure Checklist
- F&A Costs
- Fee-for-Service Agreements
- Foundation Relations
- Glossary
- Information Systems and Web-Based Applications
- Institutional Numbers and Rates
- My Grant Expenses
- Property Management Manual
- Public Health Service Agencies
- Research Computing
- Research Recovery Toolkit
- SciVal Database
- Service Center Administration
- Sponsored Research Reporting
- Report Descriptions
- Sponsored Programs Data Request Form
- Fiscal Year 2022 Reports
- Fiscal Year 2022 Sponsored Research Reports
- Fiscal Year 2021 Reports
- Fiscal Year 2021 Sponsored Research Reports
- Fiscal Year 2020 Reports
- Fiscal Year 2020 Sponsored Research Reports
- Fiscal Year 2019 Reports
- Fiscal Year 2019 Reports
- Fiscal Year 2018 Reports
- Fiscal Year 2018 Reports
- Fiscal Year 2017 Reports
- Fiscal Year 2017 Reports
- Fiscal Year 2016 Reports
- Fiscal Year 2015 Reports
- Fiscal Year 2014 Reports
- Fiscal Year 2013 Reports
- Translational Research
- Where’s My Award
- Core Facilities
- News
- Contact
- Administration
- Research – Internal Site